company background image
1093

CSPC Pharmaceutical Group SEHK:1093 Stock Report

Last Price

HK$7.16

Market Cap

HK$84.8b

7D

3.0%

1Y

-21.2%

Updated

01 Dec, 2023

Data

Company Financials +

CSPC Pharmaceutical Group Limited

SEHK:1093 Stock Report

Mkt Cap: HK$84.8b

1093 Stock Overview

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People’s Republic of China, other Asian regions, the Americas, Europe, and internationally.

1093 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth1/6
Past Performance3/6
Financial Health6/6
Dividends3/6

CSPC Pharmaceutical Group Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for CSPC Pharmaceutical Group
Historical stock prices
Current Share PriceHK$7.16
52 Week HighHK$9.56
52 Week LowHK$5.20
Beta0.88
1 Month Change4.99%
3 Month Change21.36%
1 Year Change-21.23%
3 Year Change-8.21%
5 Year Change3.99%
Change since IPO1,597.19%

Recent News & Updates

Recent updates

Are Investors Undervaluing CSPC Pharmaceutical Group Limited (HKG:1093) By 36%?

Oct 22
Are Investors Undervaluing CSPC Pharmaceutical Group Limited (HKG:1093) By 36%?

Is CSPC Pharmaceutical Group (HKG:1093) A Risky Investment?

Sep 21
Is CSPC Pharmaceutical Group (HKG:1093) A Risky Investment?

CSPC Pharmaceutical Group Limited's (HKG:1093) Intrinsic Value Is Potentially 62% Above Its Share Price

Jul 09
CSPC Pharmaceutical Group Limited's (HKG:1093) Intrinsic Value Is Potentially 62% Above Its Share Price

Does CSPC Pharmaceutical Group (HKG:1093) Have A Healthy Balance Sheet?

Jun 20
Does CSPC Pharmaceutical Group (HKG:1093) Have A Healthy Balance Sheet?

CSPC Pharmaceutical Group's (HKG:1093) Shareholders Will Receive A Bigger Dividend Than Last Year

Jun 01
CSPC Pharmaceutical Group's (HKG:1093) Shareholders Will Receive A Bigger Dividend Than Last Year

CSPC Pharmaceutical Group (HKG:1093) Is Increasing Its Dividend To CN¥0.11

Apr 04
CSPC Pharmaceutical Group (HKG:1093) Is Increasing Its Dividend To CN¥0.11

CSPC Pharmaceutical Group Limited's (HKG:1093) Intrinsic Value Is Potentially 92% Above Its Share Price

Mar 12
CSPC Pharmaceutical Group Limited's (HKG:1093) Intrinsic Value Is Potentially 92% Above Its Share Price

We Think CSPC Pharmaceutical Group (HKG:1093) Can Manage Its Debt With Ease

Dec 26
We Think CSPC Pharmaceutical Group (HKG:1093) Can Manage Its Debt With Ease

CSPC Pharmaceutical Group Limited's (HKG:1093) Intrinsic Value Is Potentially 98% Above Its Share Price

Oct 18
CSPC Pharmaceutical Group Limited's (HKG:1093) Intrinsic Value Is Potentially 98% Above Its Share Price

CSPC Pharmaceutical Group (HKG:1093) Could Easily Take On More Debt

Sep 15
CSPC Pharmaceutical Group (HKG:1093) Could Easily Take On More Debt

CSPC Pharmaceutical Group (HKG:1093) Will Pay A Larger Dividend Than Last Year At CN¥0.10

Aug 26
CSPC Pharmaceutical Group (HKG:1093) Will Pay A Larger Dividend Than Last Year At CN¥0.10

CSPC Pharmaceutical Group (HKG:1093) Will Pay A Larger Dividend Than Last Year At HK$0.10

May 27
CSPC Pharmaceutical Group (HKG:1093) Will Pay A Larger Dividend Than Last Year At HK$0.10

CSPC Pharmaceutical Group (HKG:1093) Has Announced That It Will Be Increasing Its Dividend To HK$0.10

Apr 27
CSPC Pharmaceutical Group (HKG:1093) Has Announced That It Will Be Increasing Its Dividend To HK$0.10

CSPC Pharmaceutical Group (HKG:1093) Is Increasing Its Dividend To HK$0.10

Apr 04
CSPC Pharmaceutical Group (HKG:1093) Is Increasing Its Dividend To HK$0.10

With EPS Growth And More, CSPC Pharmaceutical Group (HKG:1093) Is Interesting

Jan 12
With EPS Growth And More, CSPC Pharmaceutical Group (HKG:1093) Is Interesting

Here's Why I Think CSPC Pharmaceutical Group (HKG:1093) Is An Interesting Stock

Oct 04
Here's Why I Think CSPC Pharmaceutical Group (HKG:1093) Is An Interesting Stock

CSPC Pharmaceutical Group (HKG:1093) Is Increasing Its Dividend To HK$0.08

Aug 28
CSPC Pharmaceutical Group (HKG:1093) Is Increasing Its Dividend To HK$0.08

CSPC Pharmaceutical Group Limited (HKG:1093) Shares Could Be 40% Below Their Intrinsic Value Estimate

Aug 06
CSPC Pharmaceutical Group Limited (HKG:1093) Shares Could Be 40% Below Their Intrinsic Value Estimate

Do CSPC Pharmaceutical Group's (HKG:1093) Earnings Warrant Your Attention?

Jun 26
Do CSPC Pharmaceutical Group's (HKG:1093) Earnings Warrant Your Attention?

Shareholder Returns

1093HK PharmaceuticalsHK Market
7D3.0%1.2%-3.0%
1Y-21.2%-8.7%-7.7%

Return vs Industry: 1093 underperformed the Hong Kong Pharmaceuticals industry which returned -7.9% over the past year.

Return vs Market: 1093 underperformed the Hong Kong Market which returned -7.3% over the past year.

Price Volatility

Is 1093's price volatile compared to industry and market?
1093 volatility
1093 Average Weekly Movement5.7%
Pharmaceuticals Industry Average Movement5.7%
Market Average Movement6.5%
10% most volatile stocks in HK Market14.5%
10% least volatile stocks in HK Market3.2%

Stable Share Price: 1093 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: 1093's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199225,587Cuilong Zhanghttps://www.cspc.com.hk

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People’s Republic of China, other Asian regions, the Americas, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. It provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic Parkinson’s disease; Duomeisu for lymphoma, multiple myeloma, ovarian and breast cancers, and other malignant tumors; Jinyouli to prevent leucopenia and infection induced by chemotherapy; and Keaili for breast cancer.

CSPC Pharmaceutical Group Limited Fundamentals Summary

How do CSPC Pharmaceutical Group's earnings and revenue compare to its market cap?
1093 fundamental statistics
Market CapHK$84.84b
Earnings (TTM)HK$6.69b
Revenue (TTM)HK$34.26b

12.7x

P/E Ratio

2.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
1093 income statement (TTM)
RevenueCN¥31.31b
Cost of RevenueCN¥9.34b
Gross ProfitCN¥21.97b
Other ExpensesCN¥15.85b
EarningsCN¥6.12b

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.52
Gross Margin70.17%
Net Profit Margin19.54%
Debt/Equity Ratio0.2%

How did 1093 perform over the long term?

See historical performance and comparison

Dividends

3.9%

Current Dividend Yield

36%

Payout Ratio